Published in JAMA on November 23, 1970
Selective filtration of antibiotics through collodion membranes. Antimicrob Agents Chemother (1973) 0.97
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD. Semin Dial (2015) 0.77
Practical therapeutics in patients with renal impairment. West J Med (1992) 0.75
Effects of internal and external ionic environment on excitability of squid giant axon. A macromolecular approach. J Gen Physiol (1965) 3.95
Evaluating AICD therapy. Pacing Clin Electrophysiol (1989) 3.73
Which cyclosporin formulation? Lancet (1996) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Mechanisms of lithium action. N Engl J Med (1973) 2.90
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Effects of tetrodotoxin on excitability of squid giant axons in sodium-free media. Science (1967) 2.26
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med (1978) 1.98
Membrane macromolecules and nerve excitability: a physico-chemical interpretation of excitation in squid giant axons. Ann N Y Acad Sci (1966) 1.95
Excitation of internally perfused squid giant axons in sodium-free media. Proc Natl Acad Sci U S A (1965) 1.88
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Demeclocycline-induced nephrogenic diabetes insipidus. In-vivo and in-vitro studies. Ann Intern Med (1973) 1.60
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Excitation of squid giant axons in sodium-free external media. Am J Physiol (1966) 1.51
Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore) (1981) 1.47
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Hyponatremia, hyposmolality, and hypotonicity: tables and fables. Arch Intern Med (1999) 1.46
Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials (1991) 1.45
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Actions of insulin, epinephrine, and dibutyryl cyclic adenosine 5'-monophosphate on fat cell protein phosphorylations. Cyclic adenosine 5'-monophosphate dependent and independent mechanisms. Biochemistry (1975) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Heparin-induced aldosterone suppression and hyperkalemia. Am J Med (1995) 1.30
Excitability of squid giant axons in the absence of univalent cations in the external medium. Proc Natl Acad Sci U S A (1966) 1.25
Hypouricemia in Hodgkin's disease. Ann Intern Med (1972) 1.25
Lead nephropathy. Kidney Int (1985) 1.24
Hyponatremia: focus on therapy. South Med J (1994) 1.23
Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum (1999) 1.22
Cation interdiffusion in squid giant axons. J Gen Physiol (1967) 1.22
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med (1976) 1.20
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: effectiveness, needs, and resources. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol (1994) 1.13
Renal failure in lymphoma. Kidney Int (1980) 1.12
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Drug-induced states of nephrogenic diabetes insipidus. Kidney Int (1976) 1.09
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
The defense against hyperkalemia: the roles of insulin and aldosterone. N Engl J Med (1978) 1.08
Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. Ann Intern Med (1975) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
There should never be another antiarrhythmics versus implantable defibrillator (AVID) trial. Am J Cardiol (1997) 1.06
Some problems involved in electric measurements of biological systems. Ann N Y Acad Sci (1968) 1.06
False-positive troponin I in a patient with acute cholecystitis and positive rheumatoid factor assay. Cardiology (2001) 1.06
Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies. J Clin Invest (1972) 1.05
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Evidence for a mucosal effect of aldosterone on sodium transport in the toad bladder. J Clin Invest (1966) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
A guide to drug therapy in renal failure. JAMA (1974) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Depolarization-induced change in the enzymatic radio-iodination of a protein of the internal surface of the squid giant, axon membrane. Comp Biochem Physiol A Comp Physiol (1974) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
Effect of insulin on the phosphorylation of adipose tissue protein. Biochim Biophys Acta (1974) 0.99
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis (1986) 0.99
Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99
Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction. J Immunol (1999) 0.98
Lithium-induced ADH resistance in toad urinary bladders. Kidney Int (1973) 0.98
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97
Cyclosporine-associated hypertension. Am J Med (1988) 0.97
Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96
Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96
Interactions of amphotericin B, vasopressin, and calcium in toad urinary bladder. Am J Physiol (1969) 0.96
Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency. Am J Med (1975) 0.96
Demeclocycline and therapy of hyponatremia. Ann Intern Med (1977) 0.96
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96
Aldosterone-induced protein in toad urinary bladder. Science (1974) 0.95
Herpes simplex type 1 hepatitis in renal transplantation. Arch Intern Med (1980) 0.95